Short Interest in Bachem Holding AG (OTCMKTS:BCHMF) Grows By 45.2%

Bachem Holding AG (BCHMF) experienced a significant 45.2% increase in short interest to 380,500 shares as of mid-October, coinciding with its stock opening down 11.0% at $65.00. This rise in bearish positioning occurs amidst mixed analyst sentiment, with Jefferies initiating an "underperform" rating while Deutsche Bank recently upgraded the peptide and oligonucleotide API provider to a "buy," leading to an overall consensus "Hold" rating.

Analysis

Bachem Holding AG (BCHMF) experienced a significant 45.2% increase in short interest, reaching 380,500 shares by October 15th, up from 262,100 shares on September 30th. This surge in bearish positioning coincided with the stock opening down 11.0% at $65.00, matching its 12-month low. The reported infinite days-to-cover ratio, due to zero average daily volume, highlights extreme illiquidity and potential for amplified price movements.

The stock's current price of $65.00 sits below its 50-day moving average of $67.29 but remains above its 200-day moving average of $63.89, indicating recent downward pressure within a longer-term uptrend. The overall market sentiment for BCHMF is moderately negative and bearish, as evidenced by the sharp price decline and increased short activity.

Analyst sentiment is notably mixed, with Jefferies initiating an "underperform" rating in late September, while Deutsche Bank upgraded the stock to a "buy" in late October, leading to a consensus "Hold" rating. Bachem operates in the specialized pharmaceutical and biotechnology sector, providing peptide and oligonucleotide active pharmaceutical ingredients globally.

The substantial increase in short interest, despite the mixed analyst coverage, suggests growing investor skepticism or hedging activity. The extremely low trading volume and infinite days-to-cover ratio present a dual risk: potential for a severe short squeeze on any positive catalyst, or significant difficulty for short sellers to exit positions without further price disruption.

Key Decisions for Investors

• Investors should closely monitor Bachem's short interest and trading volume for shifts that could indicate potential volatility or a short squeeze.
• Given the extreme illiquidity and infinite days-to-cover ratio, investors must evaluate the significant risks associated with entering or exiting positions in BCHMF.
• Thoroughly assess potential catalysts or fundamental improvements that could trigger a short squeeze, considering the substantial bearish positioning.
• Exercise caution and conduct independent due diligence, as mixed analyst ratings from Jefferies and Deutsche Bank suggest a lack of clear consensus on Bachem's outlook.